Skip to main navigation Skip to search Skip to main content

Differential blood-based biomarkers of subcortical and deep brain small vessel disease

  • Pablo Hervella
  • , Maria Luz Alonso-Alonso
  • , Ana Sampedro-Viana
  • , Manuel Rodríguez-Yáñez
  • , Iria López-Dequidt
  • , José M. Pumar
  • , Alberto Ouro
  • , Daniel Romaus-Sanjurjo
  • , Francisco Campos
  • , Tomás Sobrino
  • , José Castillo
  • , Yago Leira
  • , Ramón Iglesias-Rey

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Background: Cerebral small vessel disease is the most common cause of lacunar strokes (LS). Understanding LS pathogenesis is vital for predicting disease severity, prognosis, and developing therapies. Objectives: To research molecular profiles that differentiate LS in deep brain structures from those in subcortical white matter. Design: Prospective case–control study involving 120 patients with imaging-confirmed LS and a 120 control group. Methods: We examined the relationship between Alzheimer’s disease biomarkers [amyloid beta (Aβ1–40, Aβ1–42)], serum inflammatory marker (interleukin-6, IL-6), and endothelial dysfunction markers [soluble tumor necrosis factor-like weak inducer of apoptosis, and pentraxin-3 (sTWEAK, PTX3)] with respect to LS occurring in deep brain structures and subcortical white matter. In addition, we investigated links between LS, leukoaraiosis presence (white matter hyperintensities, WMHs), and functional outcomes at 3 months. Poor outcome was defined as a modified Rankin scale >2 at 3 months. Results: Significant differences were observed in levels of IL-6, PTX3, and sTWEAK between patients with deep lacunar infarcts and those with recent small subcortical infarcts (20.8 versus 15.6 pg/mL, p < 0.001; 7221.3 versus 4624.4 pg/mL, p < 0.0001; 2528.5 versus 1660.5 pg/mL, p = 0.001). Patients with poor outcomes at 3 months displayed notably higher concentrations of these biomarkers compared to those with good outcomes. By contrast, Aβ1–40 and Aβ1–42 were significantly lower in patients with deep LS (p < 0.0001). Aβ1–42 levels were significantly higher in patients with LS in subcortical white matter who had poor outcomes. WMH severity only showed a significant association with deep LS and correlated with sTWEAK (p < 0.0001). Conclusion: The pathophysiological mechanisms of lacunar infarcts in deep brain structures seem different from those in the subcortical white matter. As a result, specific therapeutic and preventive strategies should be explored.

Original languageEnglish
JournalTherapeutic Advances in Neurological Disorders
Volume17
DOIs
StatePublished - 1 Jan 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • cerebral small vessel disease
  • ischemic stroke
  • lacunar stroke
  • leukoaraiosis
  • white matter hyperintensities

ASJC Scopus subject areas

  • Pharmacology
  • Neurology
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Differential blood-based biomarkers of subcortical and deep brain small vessel disease'. Together they form a unique fingerprint.

Cite this